Professor Dang Duc Anh, head of Vaccine and Biological Production 1 (Vabiotech), co-operated with Hanoi Medical University to the first stage of human trials.
According to the result of the first trial phase, the vaccine proved safe and immunogenic.
"The vaccine sample has been sent to Canada for being assessed in terms of the immune response capacity. Once the outcome is positive, we’ll seek the Ministry of Health’s permission for the second trial which is expected to take place in Thai Binh from July,” Anh added.
When the second trial stage is successful, the third trial phase will be carried out by the end of this year. The vaccine is hoped to be put into use officially early next year.
Covivac is Vietnam's second vaccine licensed for trial on humans.
Meanwhile, Nanocovax, another Made-in-Vietnam Covid-19 vaccine is in the third trial phase which covers more than 13,000 volunteers. All of the people are scheduled to be given a second shot before August 15.
